SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 98 filers reported holding SERES THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $231,659,000 | -5.1% | 9,713,160 | -18.1% | 0.43% | -11.1% |
Q1 2021 | $244,114,000 | -27.5% | 11,855,947 | -13.7% | 0.48% | -45.9% |
Q4 2020 | $336,661,000 | -3.3% | 13,741,254 | +11.8% | 0.90% | -56.6% |
Q3 2020 | $348,016,000 | +485.9% | 12,293,033 | -1.5% | 2.06% | +223.0% |
Q2 2020 | $59,400,000 | +92.4% | 12,478,934 | +44.3% | 0.64% | -16.9% |
Q1 2020 | $30,871,000 | +23.0% | 8,647,311 | +18.9% | 0.77% | +21.5% |
Q4 2019 | $25,095,000 | -11.5% | 7,273,840 | +2.8% | 0.63% | +2.3% |
Q3 2019 | $28,371,000 | +25.2% | 7,074,965 | +0.5% | 0.62% | +8.4% |
Q2 2019 | $22,665,000 | -37.6% | 7,038,885 | +33.1% | 0.57% | -45.0% |
Q1 2019 | $36,327,000 | +95.1% | 5,287,713 | +28.4% | 1.04% | +37.3% |
Q4 2018 | $18,620,000 | -39.3% | 4,119,479 | +1.9% | 0.76% | -18.4% |
Q3 2018 | $30,669,000 | +9.2% | 4,040,735 | +23.7% | 0.93% | -9.9% |
Q2 2018 | $28,091,000 | +59.0% | 3,266,428 | +35.7% | 1.03% | +17.3% |
Q1 2018 | $17,665,000 | +7.2% | 2,406,723 | +48.1% | 0.88% | -33.2% |
Q4 2017 | $16,483,000 | +90.6% | 1,625,501 | +112.4% | 1.31% | -22.0% |
Q2 2017 | $8,647,000 | +21.8% | 765,191 | +21.5% | 1.68% | -17.7% |
Q1 2017 | $7,099,000 | +45.7% | 629,915 | +28.0% | 2.05% | +15.5% |
Q4 2016 | $4,871,000 | – | 492,064 | – | 1.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
Knott David M Jr | 470,000 | $2,251 | 0.90% |
GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |